Literature DB >> 20065946

Involvement of the IL-22/REG Ialpha axis in ulcerative colitis.

Akira Sekikawa1, Hirokazu Fukui, Katsumasa Suzuki, Toyohiko Karibe, Shigehiko Fujii, Kazuhito Ichikawa, Shigeki Tomita, Johji Imura, Keiko Shiratori, Tsutomu Chiba, Takahiro Fujimori.   

Abstract

The Regenerating gene (REG) Ialpha protein, a trophic and/or anti-apoptotic factor, is important in the pathophysiology of gastrointestinal inflammation. Interleukin (IL)-22 is a recently identified cytokine that is suggested to have pivotal roles in inflammatory bowel diseases. We therefore investigated the involvement of the IL-22/REG Ialpha axis and examined the mechanism of regulation of REG Ialpha expression by IL-22 stimulation in ulcerative colitis (UC) mucosa. Expression of IL-22, IL-22 receptor 1 (IL-22R1), and REG Ialpha in UC mucosa was analyzed by real-time RT-PCR and immunohistochemistry. The effects of IL-22 on REG Ialpha protein expression were examined using a small-interfering RNA for STAT3, an MAPK inhibitor or a PI3K inhibitor. The element responsible for IL-22-induced REG Ialpha promoter activation was determined by a promoter deletion and electrophoretic mobility shift assay. The expression of IL-22 was enhanced in infiltrating inflammatory cells, and that of IL-22R1 and REG Ialpha was concurrently enhanced in the inflamed epithelium in UC mucosa. The levels of REG Ialpha and IL-22 mRNA expression were strongly correlated, and the distributions of REG Ialpha- and IL-22R1-positive epithelial cells were very similar. IL-22 simulation enhanced the expression of REG Ialpha protein through STAT3 tyrosine phosphorylation in colon cancer cells. The IL-22-responsive element was located between -142 and -134 in the REG Ialpha promoter region. REG Ialpha protein may have a pathophysiological role as a biological mediator for immune cell-derived IL-22 in the UC mucosa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065946     DOI: 10.1038/labinvest.2009.147

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  46 in total

Review 1.  Animal models of IBD: linkage to human disease.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  Curr Opin Pharmacol       Date:  2010-06-08       Impact factor: 5.547

Review 2.  Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.

Authors:  Ning Zhang; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Cell Biochem       Date:  2011-03-08       Impact factor: 3.396

3.  Expression of human REG family genes in inflammatory bowel disease and their molecular mechanism.

Authors:  Shin Takasawa; Chikatsugu Tsuchida; Sumiyo Sakuramoto-Tsuchida; Maiko Takeda; Asako Itaya-Hironaka; Akiyo Yamauchi; Masayasu Misu; Ryogo Shobatake; Tomoko Uchiyama; Mai Makino; Chiho Ohbayashi
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

4.  Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Authors:  Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper
Journal:  J Proteome Res       Date:  2012-10-26       Impact factor: 4.466

5.  REG1B as a predictor of childhood stunting in Bangladesh and Peru.

Authors:  Kristine M Peterson; Janice Buss; Rebecca Easley; Zhengyu Yang; Poonum S Korpe; Feiyang Niu; Jennie Z Ma; Maribel Paredes Olortegui; Rashidul Haque; Margaret N Kosek; William A Petri
Journal:  Am J Clin Nutr       Date:  2013-04-03       Impact factor: 7.045

6.  Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.

Authors:  Rong-Hua Song; Zhi-Yun Yu; Qiu Qin; Xuan Wang; Fatuma-Said Muhali; Liang-Feng Shi; Wen-Juan Jiang; Ling Xiao; Dan-Feng Li; Jin-An Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

7.  Up-regulated Reg proteins induced by Interleukin-22 treatment ameliorate acute liver injury in rat model.

Authors:  Hong-Bin Zhang; Hong-Chun Luo; Xiao-Juan Xin; Ai-Zhong Zeng
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 8.  The gastrointestinal tumor microenvironment.

Authors:  Michael Quante; Julia Varga; Timothy C Wang; Florian R Greten
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

9.  Interleukin 22 polymorphisms and papillary thyroid cancer.

Authors:  Y G Eun; I H Shin; Y C Lee; S Y Shin; S K Kim; J H Chung; K H Kwon
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

10.  Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.

Authors:  Lian-Zhen Yu; Hai-Yang Wang; Shu-Ping Yang; Zhi-Ping Yuan; Fang-Yuan Xu; Chao Sun; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.